Expanding Translational Research in Arkansas
扩大阿肯色州的转化研究
基本信息
- 批准号:9893085
- 负责人:
- 金额:$ 411.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAfrican AmericanAreaArkansasCardiovascular DiseasesClinical ResearchClinical and Translational Science AwardsCollaborationsCommunitiesComplexDeath RateDiabetes MellitusEcosystemEnvironmentFacultyFosteringFoundationsFutureGrowthHealthHealth BenefitHealthcareHealthcare SystemsHome environmentIndividualInformaticsInstitutionInterdisciplinary StudyInterventionKnowledgeLeadLinkLongevityMeasurableMedicalMethodsMinorityMissionObesityPediatric HospitalsPopulationPositioning AttributePovertyProcessResearchResearch InstituteResearch MethodologyResearch PersonnelResearch SupportResearch TrainingResistanceResourcesRewardsRuralRural PopulationScienceSiteTrainingTranslational ResearchUnderrepresented PopulationsUniversitiesVeteransVisionWorkbasecareercareer developmentimprovedinnovationmetropolitannovel strategiesprogramsrural areasuccesstranslational scientist
项目摘要
The health challenges of Arkansas mandate that the University of Arkansas for Medical Sciences (UAMS)
Translational Research Institute (TRI) works in partnership with communities and stakeholders to develop and
conduct clinical and translational research (CTR) that will measurably improve the health of Arkansans. As the
academic home for translational researchers, our Clinical and Translational Science Award (CTSA) hub has
developed efficient and resourceful workflows, established excellent research training and educational
programs, and launched initiatives to support the growth of team science and community engagement. With
maturation of our hub, we have expanded our integration with our participating sites, Arkansas Children’s
Hospital (ACH) and the Central Arkansas Veteran’s Healthcare System (CAVHS), which provides us with
diverse perspectives and a collaborative foundation of multidisciplinary research across these three closely-
linked institutions. Collectively, hub faculty from UAMS, ACH, and CAVHS have rich expertise in CTR
engaging rural and underrepresented populations and will help us expand CTR resources more broadly. Our
vision is to be a thriving translational research ecosystem that catalyzes discoveries into health solutions for
rural and underrepresented populations. Our future work, based on our previous accomplishments, will be
guided by the following five specific aims: Aim 1). Enrich our environment for CTR by supporting and rewarding
team-based collaborations at the local and national level; Aim 2). Enhance training to researchers across the
translational research spectrum and at all career levels through innovative and team-based approaches; Aim
3). Increase partnerships with diverse stakeholders to expand the impact of clinical and translational research
in and with rural populations; Aim 4). Streamline translational research processes and enhance research
quality with state-of-the-art informatics approaches and methods; and Aim 5). Expand clinical and translational
research opportunities across the lifespan and in underrepresented populations. The collective impact of our
success as a CTSA hub will provide “real world solutions” for effective CTR in rural and underrepresented
populations, a facet insufficiently represented within the CTSA Consortium.
阿肯色州的健康挑战要求阿肯色医学大学 (UAMS)
转化研究所 (TRI) 与社区和利益相关者合作开发和
进行临床和转化研究(CTR),以显着改善阿肯色州人的健康。
我们的临床和转化科学奖 (CTSA) 中心是转化研究人员的学术家园
开发高效且资源丰富的工作流程,建立优秀的研究培训和教育
计划,并发起了支持团队科学和社区参与发展的举措。
随着我们中心的成熟,我们扩大了与参与地点阿肯色州儿童医院的整合
医院 (ACH) 和阿肯色州中部退伍军人医疗保健系统 (CAVHS),它为我们提供了
不同的观点和跨这三个密切相关的多学科研究的协作基础
UAMS、ACH 和 CAVHS 的教职中心共同拥有丰富的 CTR 专业知识。
吸引农村和代表性不足的人群,并将帮助我们更广泛地扩大 CTR 资源。
愿景是成为一个蓬勃发展的转化研究生态系统,将发现转化为健康解决方案
基于我们之前的成就,我们未来的工作将是农村和代表性不足的人口。
遵循以下五个具体目标: 目标 1) 通过支持和奖励丰富我们的 CTR 环境。
地方和国家层面的团队合作;目标 2)。
通过创新和基于团队的方法,在各个职业层面开展转化研究;
3). 加强与不同利益相关者的合作,以扩大临床和转化研究的影响
目标 4) 简化转化研究流程并加强研究。
采用最先进的信息学方法和方法来提高质量;以及扩大临床和转化。
整个生命周期和代表性不足的人群的研究机会我们的集体影响。
作为 CTSA 中心的成功将为农村和代表性不足的地区有效的点击率提供“现实世界的解决方案”
CTSA 联盟中代表性不足的一个方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura P James其他文献
Hands-Free Analytical Urine Testing Technology Validated for Drug-Facilitated Crime Investigations.
免提分析尿液检测技术经过验证可用于毒品犯罪调查。
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:4.1
- 作者:
Marina Avram;Carter Bodinger;Madeline A Clark;Daniel G Stuckey;Samuel E Mathews;Susan N Stogsdill;Elyse C Barna;David K Williams;Mitchell R. McGill;W. Fantegrossi;Erica L Liebelt;Laura P James;G. Endres;Jeffery H Moran - 通讯作者:
Jeffery H Moran
Laura P James的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura P James', 18)}}的其他基金
CTSA Admin Supp2 Maternal Mortality - UL1 - Revision
CTSA Admin Supp2 孕产妇死亡率 - UL1 - 修订版
- 批准号:
10200507 - 财政年份:2020
- 资助金额:
$ 411.31万 - 项目类别:
CTSA Admin Supp QAQC - UL1 - Revision
CTSA 管理补充 QAQC - UL1 - 修订版
- 批准号:
10158964 - 财政年份:2019
- 资助金额:
$ 411.31万 - 项目类别:
Arkansas ECHO ISPCTN Site (AREIS)
阿肯色州 ECHO ISPCTN 站点 (AREIS)
- 批准号:
10063720 - 财政年份:2016
- 资助金额:
$ 411.31万 - 项目类别:
Arkansas Center for Advancing Pediatric Therapeutics (ArCAPT)
阿肯色州儿科治疗促进中心 (ArCAPT)
- 批准号:
9262528 - 财政年份:2016
- 资助金额:
$ 411.31万 - 项目类别:
Dipstick Assay for Detection of Acetaminophen Protein Adducts
用于检测对乙酰氨基酚蛋白加合物的试纸测定
- 批准号:
8013387 - 财政年份:2010
- 资助金额:
$ 411.31万 - 项目类别:
Biomarkers of adverse responses to acetaminophen in children and adolescents
儿童和青少年对乙酰氨基酚不良反应的生物标志物
- 批准号:
8252206 - 财政年份:2009
- 资助金额:
$ 411.31万 - 项目类别:
Identification of new mechanistic biomarkers of adverse responses to acetaminophe
对乙酰氨基酚不良反应的新机制生物标志物的鉴定
- 批准号:
8063985 - 财政年份:2009
- 资助金额:
$ 411.31万 - 项目类别:
相似海外基金
DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
- 批准号:
10558119 - 财政年份:2023
- 资助金额:
$ 411.31万 - 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 411.31万 - 项目类别:
Role of YB1 in health disparities in triple negative breast cancer
YB1 在三阴性乳腺癌健康差异中的作用
- 批准号:
10655943 - 财政年份:2023
- 资助金额:
$ 411.31万 - 项目类别:
The Meharry Cancer Summer Research Program (SuRP)
梅哈里癌症夏季研究计划 (SuRP)
- 批准号:
10715291 - 财政年份:2023
- 资助金额:
$ 411.31万 - 项目类别:
The role of the contextual food environment and community programs and policies on diet and dietary disparities in the national Healthy Communities Study
背景食物环境和社区计划以及饮食政策和饮食差异在国家健康社区研究中的作用
- 批准号:
10730780 - 财政年份:2023
- 资助金额:
$ 411.31万 - 项目类别: